Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hemophilia A
Related studies linked through entity extraction aliases.
Characterizing the Impact and Treatment of Reproductive Tract Bleeding on Women and Post-menarchal Girls With Bleeding Disorders
- Status
- COMPLETED
- Phase
- N/A
Post Marketing Surveillance Study for ADYNOVATE in South Korea
- Status
- COMPLETED
- Phase
- N/A
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
- Status
- COMPLETED
- Phase
- N/A
Evaluation of SCT800 in Prophylaxis Therapy on Previous Treated Patients With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Pharmacokinetics of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
- Status
- UNKNOWN
- Phase
- N/A
Early Check: Expanded Screening in Newborns
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Personalized Medicine for Canadians With Hemophilia
- Status
- UNKNOWN
- Phase
- NA
Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry
- Status
- TERMINATED
- Phase
- N/A
Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)
- Status
- COMPLETED
- Phase
- PHASE3
Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability
- Status
- UNKNOWN
- Phase
- N/A
Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Virtual Reality for Hemophilia
- Status
- COMPLETED
- Phase
- NA
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies
- Status
- COMPLETED
- Phase
- N/A
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
- Status
- COMPLETED
- Phase
- PHASE3